Home / Weight Loss
GLP-1 weight lossSix ways to start. One care team.
Two weekly injections, a low-dose microdose option, two daily oral troches, and the FDA-approved brand products. Every option includes your provider evaluation, ongoing check-ins, unlimited care-team messaging, and free shipping. Your provider recommends the option that fits your health history, goals, and preferences. The eligibility check is free.
Programs
Semaglutide Injection
One injection per week · GLP-1 receptor agonist
$179 your first month
Start my programCompounded, not FDA-approved.*
Tirzepatide Injection
One injection per week · dual-action GIP/GLP-1
Flat pricing, every month
Start my programCompounded, not FDA-approved.*
GLP-1 Microdose
One low-dose injection per week · fixed dose, no titration
Semaglutide $199 · tirzepatide $249
Start my programCompounded, not FDA-approved.*
Oral Semaglutide (ODT)
One dissolving troche per day · needle-free
30-count · no refrigeration
Start my programCompounded, not FDA-approved.*
Oral Tirzepatide (ODT)
One dissolving troche per day · needle-free
30-count · no refrigeration
Start my programCompounded, not FDA-approved.*
Brand-name GLP-1
Wegovy®, Zepbound®, Ozempic® or Mounjaro®
+ medication cost · availability subject to change
Start my assessmentDiscussed with your provider during your GLP-1 assessment. Not sold separately online.
Wegovy® and Zepbound® are FDA-approved for chronic weight management. Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes and would be prescribed off-label, at your provider’s discretion.
If prescribed, your medication will be dispensed by Rush Pharmacy, a licensed pharmacy. Brand-name prescriptions are the exception: they are filled and billed by a retail or manufacturer pharmacy.
*Compounded medications are prepared by state-licensed compounding pharmacies pursuant to a prescription. They are not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs before marketing. Brand names are trademarks of their respective owners. Row Telehealth is not affiliated with those manufacturers. Starting a program does not guarantee a prescription. If your provider decides treatment is not appropriate for you, you are not charged for medication.
How GLP-1 dosing works
GLP-1 medications are usually started at a low dose and increased gradually over several weeks to months. This step-by-step approach, called titration, gives your body time to adjust and helps limit side effects such as nausea. There is no single standard dose that fits everyone.
- Your provider sets your dose. Your starting dose, when it changes, and where it settles are decided by your provider based on your health history, how you respond, and any side effects you report.
- Changes happen at check-ins. Your dose is reviewed at each check-in. It may go up, stay the same, or come down. Staying on a lower dose is a normal outcome.
- Follow your own prescription. Always take your medication exactly as your provider prescribed and as the pharmacy label directs. Do not change your dose on your own. If you have questions, message your care team.
- Injections and oral troches differ. Oral and injectable forms are absorbed differently, so their doses are not interchangeable. Your provider explains what applies to the form you are prescribed.
General information only. This section explains how dosing generally works. It is not a dosing schedule and is not a substitute for your provider's instructions. Compounded formulations are not FDA-approved, and depending on the dispensing pharmacy they may be co-formulated with vitamin B6 or vitamin B12.
Which option is right for you?
Semaglutide
The most-prescribed starting point. Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and slow stomach emptying, so you feel full sooner and stay satisfied longer. Your provider sets the dose and adjusts it at check-ins.
- Dosing Weekly subcutaneous injection. Started low and adjusted gradually by your provider
- Best for First-time GLP-1 patients
- Common side effects Nausea, constipation, diarrhea, reduced appetite, usually strongest during dose increases
- Not for you if Personal/family history of medullary thyroid carcinoma or MEN 2, history of pancreatitis, pregnancy
Tirzepatide
A dual-action option: tirzepatide activates both GIP and GLP-1 receptors. Often chosen by patients who plateaued on semaglutide or want a dual-pathway option.
- Dosing Weekly subcutaneous injection. Started low and adjusted gradually by your provider
- Best for Patients who plateaued on semaglutide, or whose provider recommends a dual-pathway option
- Common side effects Nausea, constipation, diarrhea, reduced appetite. The same GI profile as semaglutide, usually strongest during dose increases
- Not for you if Same exclusions as semaglutide (MTC/MEN 2, pancreatitis history, pregnancy)
Oral semaglutide and oral tirzepatide
The same two molecules in a troche that dissolves in the mouth once a day, no needles, no refrigeration, easy to travel with. A good fit if injections are a dealbreaker. Oral absorption works differently from an injection, so oral and injectable doses are not interchangeable. Your provider will set expectations accordingly.
- Dosing One troche dissolved in the mouth daily. Started low and adjusted gradually by your provider
- Best for Needle-averse patients. Frequent travelers. Anyone without reliable refrigeration
- Common side effects Same GI class effects as the injectables, plus possible mouth or throat irritation
- Not for you if Same exclusions as the injectable GLP-1s
Wegovy®, Zepbound®, Ozempic® and Mounjaro®
Prefer the FDA-approved brand products? Your membership covers the provider relationship, check-ins, and care-team support. The medication is filled at a retail or manufacturer pharmacy and billed by that pharmacy. Wegovy® (semaglutide) and Zepbound® (tirzepatide) are FDA-approved for chronic weight management. Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes. A provider may prescribe them off-label only where they judge that appropriate for you.
- Dosing Weekly pen injection. Your provider follows the manufacturer’s prescribing information
- Best for Patients who want an FDA-approved product, or whose provider determines a brand product is the appropriate choice
- Availability Subject to change with manufacturer supply. Which product is prescribed is your provider’s decision
Compounded formulations are not FDA-approved. Individual results vary. No outcome is guaranteed.
Not sure which is right for you?
Take the 5-minute assessment. Your provider will recommend the best fit for your history and goals.
Start my assessment